JD
Joris De Maeyer
Executive in Residence at Bioqube Ventures
Mechelen, Flemish Region
Overview
Joris De Maeyer is an accomplished Executive in the Biotech and Venture Capital industries, currently serving as an Executive in Residence and Investment Director at Bioqube Ventures. With a Ph.D. from Ghent University and extensive experience in leadership roles at companies like Facio Therapies and Shire, he excels in driving drug discovery and development initiatives while also providing strategic guidance and mentorship to emerging ventures in the pharmaceutical and biotech sectors.
Work Experience
Executive in Residence
2023 - Current
Investment Director
2020 - 2023
Venture Coach
2016 - 2020
Board Observer
2021
Founder
2023
Managing Director - Life Science Consulting
2013
Chief Executive Officer
2021 - 2022
Acting Chief Executive Officer
2021 - 2021
Chief Scientific Officer
2019 - 2021
Director R&D
2014 - 2019
Director Discovery
2011 - 2013
Manager Drug Discovery
2007 - 2010
Research Associate Drug Discovery
2002 - 2006
Senior Associate Quality Assurance Preclinical Research & Development (PKPD TOX)
2001 - 2002
Johnson & Johnson is a healthcare provider, expertise in innovative medicine and MedTech for every patient & for everyone.
Auditor Surface Water Monitoring Network
2001 - 2001
Temporary assignment.
Research associate
2000 - 2001
Education
PhD
2002 - 2008
Master's degree
1994 - 2000